World Journal of Nuclear Medicine : Table of Contents

Home

About us

Editorial board

Ahead of print

Current issue

Archives

Submit article

Instructions

Contacts

Users Online: 312

Article Cited by others

ORIGINAL ARTICLE

¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy in metastatic or advanced and inoperable primary neuroendocrine tumors of rare sites

Thapa Pradeep, Parghane Rahul, Basu Sandip

Year : 2017| Volume: 16| Issue : 3 | Page no: 223-228

This article has been cited by

1	The battle on time, money and precision: Da[18F] id vs. [68Ga]liath

	Sabri Sahnoun,Patrick Conen,Felix M. Mottaghy

	European Journal of Nuclear Medicine and Molecular Imaging. 2020;

	[Pubmed] [Google Scholar] [DOI]

2	A rare rarity: Neuroendocrine tumor of the esophagus

	Elisa Giannetta,Valentina Guarnotta,Francesca Rota,Federica de Cicco,Federica Grillo,Annamaria Colao,Antongiulio Faggiano

	Critical Reviews in Oncology/Hematology. 2019; 137: 92

	[Pubmed] [Google Scholar] [DOI]